Search for: "Eli, Inc." Results 461 - 480 of 1,001
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jul 2010, 1:32 pm by Richard Renner
Grassley letters are available in the continuation of this blog entryBelow are links to the letters sent by Grassley to: Abbott Laboratories Amgen AstraZeneca Pharmaceuticals Boehringer Bristol-Myers Squibb Company Eisai Corporation of America Eli Lilly and Company Forest Laboratories GlaxoSmithKline Hoffman-La Roche Inc. [read post]
7 Nov 2015, 2:36 pm by Michael Rosenblat
  The United States Attorney’s Office for the Eastern District of Pennsylvania and the United States Department of Justice are now requesting information from Eli Lilly and Company, and Valeant Pharmaceuticals International, Inc. [read post]
10 Jan 2012, 11:58 pm by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
3 Nov 2010, 1:21 am by Kelly
Highlights this week included: US Supreme Court to hear Bayh-Dole patent ownership dispute: Stanford v Roche (Patently-O) (IPKat) (IPBiz) US DoJ amicus brief in Myriad says no to patentability of genomic DNA: AMP v USPTO (IPBiz) (Inventive Step) (Patently-O) (Patent Docs) (Holman’s Biotech IP Blog) Gemzar (Gemcitabine) – US: CAFC denies en banc rehearing of ‘distorted’ law of double-patenting: Sun Pharmaceuticals v Eli Lilly (Peter Zura’s 271 Patent Blog)… [read post]
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
23 Feb 2016, 1:53 am
Hoffmann-La Roche AG and Genentech Inc. [read post]
7 Mar 2016, 1:55 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive… [read post]
2 Sep 2009, 8:04 am
Pfizer Inc agreed to plead guilty to a U.S. criminal charge relating to promotion of its now-withdrawn Bextra pain medicine and will pay a record $2.3 billion to settle allegations it improperly marketed 13 medicines. [read post]